Table 4.
Oxidized low-density lipoprotein content, their antibodies in the serum of patients with myocardial infarction and in normal subjects
| Variables | Control (n = 33) | Killip I (n = 47) | Killip II–IV (n = 32) | ||
|---|---|---|---|---|---|
|
|
|
||||
| Day 1 | Day 12 | Day 1 | Day 12 | ||
| Oxidized LDL, ng/mL | 345.6 (299.2–405.5) | 470.04 (420–563.1)a | 629.2 (589.6–690.9)b | 524.04 (489.7–589.5)a,c | 712.71 (658.2–801.1)b |
| oLABIgG, mU/mL | 201.82 (150.2–251.3) | 308.87 (255.1–372.1)a | 324.94 (290.9–380.1) | 345.99 (301.9–402.1)a,c | 373.79 (332.5–489.2) |
Notes:
a
Compared with the control group (P < 0.05);
b
reliable differences in indicators on day 1 and day 12 (P < 0.05);
c
reliable differences in indicators for Killip I and Killip II–IV groups (P < 0.05).
Abbreviations: Oxidized LDL, oxidative modification of low-density lipoproteins; oLABIgG, oxidative modification of antibodies of low-density lipoproteins.